These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16971092)

  • 1. Substance abuse in first-episode non-affective psychosis.
    Larsen TK; Melle I; Auestad B; Friis S; Haahr U; Johannessen JO; Opjordsmoen S; Rund BR; Simonsen E; Vaglum P; McGlashan TH
    Schizophr Res; 2006 Dec; 88(1-3):55-62. PubMed ID: 16971092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involuntary hospitalization of first-episode psychosis with substance abuse during a 2-year follow-up.
    Opsal A; Clausen T; Kristensen O; Elvik I; Joa I; Larsen TK
    Acta Psychiatr Scand; 2011 Sep; 124(3):198-204. PubMed ID: 21418161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suicidality before and in the early phases of first episode psychosis.
    Barrett EA; Sundet K; Faerden A; Nesvåg R; Agartz I; Fosse R; Mork E; Steen NE; Andreassen OA; Melle I
    Schizophr Res; 2010 Jun; 119(1-3):11-7. PubMed ID: 20399077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of screening instruments for detecting alcohol and other drug use disorders in first-episode psychosis.
    Nesvåg R; Lange EH; Faerden A; Barrett EA; Emilsson B; Ringen PA; Andreassen OA; Melle I; Agartz I
    Psychiatry Res; 2010 May; 177(1-2):228-34. PubMed ID: 20178887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse.
    Møller T; Linaker OM
    Nord J Psychiatry; 2004; 58(3):237-42. PubMed ID: 15204212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and violent behavior in persons with first episode psychosis during a 10-year prospective follow-up study.
    Langeveld J; Bjørkly S; Auestad B; Barder H; Evensen J; Ten Velden Hegelstad W; Joa I; Johannessen JO; Larsen TK; Melle I; Opjordsmoen S; Røssberg JI; Rund BR; Simonsen E; Vaglum P; McGlashan T; Friis S
    Schizophr Res; 2014 Jul; 156(2-3):272-6. PubMed ID: 24837683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis.
    Moore E; Mancuso SG; Slade T; Galletly C; Castle DJ
    Aust N Z J Psychiatry; 2012 Sep; 46(9):864-78. PubMed ID: 22472772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifetime history of substance misuse in first-episode psychosis: prevalence and its influence on psychopathology and onset of psychotic symptoms.
    Kamali M; McTigue O; Whitty P; Gervin M; Clarke M; Browne S; Larkin C; O'Callaghan E
    Early Interv Psychiatry; 2009 Aug; 3(3):198-203. PubMed ID: 22640383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance use and abuse in first-episode psychosis: prevalence before and after early intervention.
    Archie S; Rush BR; Akhtar-Danesh N; Norman R; Malla A; Roy P; Zipursky RB
    Schizophr Bull; 2007 Nov; 33(6):1354-63. PubMed ID: 17337748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression and depressive symptoms in first episode psychosis.
    Romm KL; Rossberg JI; Berg AO; Barrett EA; Faerden A; Agartz I; Andreassen OA; Melle I
    J Nerv Ment Dis; 2010 Jan; 198(1):67-71. PubMed ID: 20061872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use disorders among treatment naïve first-episode psychosis patients.
    Chand P; Thirthalli J; Murthy P
    Compr Psychiatry; 2014 Jan; 55(1):165-9. PubMed ID: 24183888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in young adults with first-episode schizophrenia spectrum disorders at baseline in the Danish OPUS study.
    Thorup A; Petersen L; Jeppesen P; Ohlenschlaeger J; Christensen T; Krarup G; Jorgensen P; Nordentoft M
    J Nerv Ment Dis; 2007 May; 195(5):396-405. PubMed ID: 17502805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance misuse at presentation to an early psychosis program.
    Van Mastrigt S; Addington J; Addington D
    Soc Psychiatry Psychiatr Epidemiol; 2004 Jan; 39(1):69-72. PubMed ID: 15022049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of psychotic and non-psychotic disorders in relatives of patients with a first episode psychosis.
    Faridi K; Pawliuk N; King S; Joober R; Malla AK
    Schizophr Res; 2009 Oct; 114(1-3):57-63. PubMed ID: 19666214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories.
    Iyer SN; Boekestyn L; Cassidy CM; King S; Joober R; Malla AK
    Psychol Med; 2008 Aug; 38(8):1147-56. PubMed ID: 18366823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of premorbid functioning in first episode psychosis: relationship to 2-year outcome.
    Addington J; Addington D
    Acta Psychiatr Scand; 2005 Jul; 112(1):40-6. PubMed ID: 15952944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term level of functioning in patients admitted for psychotic disorders with and without substance abuse.
    Møller T; Linaker OM
    Nord J Psychiatry; 2006; 60(2):121-5. PubMed ID: 16635930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhalant abusers and psychiatric symptoms].
    Okudaira K; Yabana T; Takahashi H; Iizuka H; Nakajima K; Saito A
    Seishin Shinkeigaku Zasshi; 1996; 98(4):203-12. PubMed ID: 8710994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.